AzTrials
AzTrials

DyspneaNCT05647655

Value of Transthoracic Ultrasonography (TTU) for Etiological Diagnosis of Acute Dyspnea: Cross Sectional Study

An observational study of Dyspnea, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluating the capability and efficiency of transthoracic ultrasound in attempting to identify the etiology of acute dyspnea. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dyspnea
What is being tested?
Ultrasonography
Type of treatment
Medical device
How many people
143 participants
Where
1 siteEgypt
Study dates
20 Feb 2023to 1 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients older than 18 years with acute dyspnea will be included

Who may be able to join

  • Clinical history of acute dyspnea

Who cannot join

  • Subcutaneous emphysema.
  • Patients with more than 24 h interval between HRCT and TTU.
  • Patients with poor-quality of TTU image.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Assiut University hospital

    Asyut, 71515

    Mohamed A Hefny, MD, 01009319309, dr.m.tawab@gmail.com

    Recruiting

Other trials in Egypt

About this study

Evaluating the capability and efficiency of transthoracic ultrasound in attempting to identify the etiology of acute dyspnea.

Read the detailed description

Acute dyspnea is a frequent challenge for physicians due to having multiple etiologies, leading to difficulty in establishing an accurate diagnosis.

The presence of this symptom is already a predictor of increased mortality and a lot of investigations are required to differentiate between etiologies. Hence, prompt diagnosis is needed to streamline these patients' appropriate management and disposition from the ED.

Transthoracic ultrasound has traditionally been used for the detection of pleural effusion and evaluation of the chest wall, but the indications have been expanded.

The gold standard imaging technique for the majority of pulmonary disorders is high-resolution computed tomography (HRCT), but it has negatives which are:

  • hazard of ionizing radiation
  • high cost
  • being nonportable
Conditions
Dyspnea
Being tested
Ultrasonography
Medical subject headings
Dyspnea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UltrasonographyDevice

    Bedside thoracic ultrasound for patients complaining of acute dyspnea.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differentiate between different etiologies of acute dyspnea

    Analysis of ultrasound findings to differentiate between etiologies of acute dyspnea.

    Measured: Baseline

Secondary outcomes (1)
  1. Detect value of transthoracic ultrasound (TTU) in comparison to CT chest.

    Comparison between accuracy of TTU and CT

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2022
  2. Study start20 Feb 2023
  3. Primary completion1 Mar 2024 (estimated)
  4. Study completion1 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
143 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05647655
Sponsor's protocol ID
US in Acute dyspnea
Status last verified
Dec 2022
First submitted
3 Dec 2022
Last updated
24 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Gargani L, Fontana M, Sicari R, Picano E. [Differential diagnosis of dyspnea: the incremental value of lung ultrasound]. Recenti Prog Med. 2010 Feb;101(2):78-82. Italian.

    PubMed 20433006
  • Baid H, Vempalli N, Kumar S, Arora P, Walia R, Chauhan U, Shukla K, Verma A, Chawang H, Agarwal D. Point of care ultrasound as initial diagnostic tool in acute dyspnea patients in the emergency department of a tertiary care center: diagnostic accuracy study. Int J Emerg Med. 2022 Jun 13;15(1):27. doi: 10.1186/s12245-022-00430-8.

    PubMed 35698060
  • Vitturi N, Soattin M, Allemand E, Simoni F, Realdi G. Thoracic ultrasonography: A new method for the work-up of patients with dyspnea(). J Ultrasound. 2011 Sep;14(3):147-51. doi: 10.1016/j.jus.2011.06.009. Epub 2011 Jun 30.

    PubMed 23396858
  • Li H, Li YD, Zhu WW, Sun LL, Ye XG, Kong LY, Cai QZ, Jiang W, Wang L, Lu XZ. High-Resolution Transthoracic Ultrasonography for Assessment of Pleural Lines in Patients With Dyspnea With CT Comparison: An Observational Study. J Ultrasound Med. 2017 Apr;36(4):707-716. doi: 10.7863/ultra.16.04030. Epub 2017 Jan 27.

    PubMed 28127786
  • Lancellotti P, Price S, Edvardsen T, Cosyns B, Neskovic AN, Dulgheru R, Flachskampf FA, Hassager C, Pasquet A, Gargani L, Galderisi M, Cardim N, Haugaa KH, Ancion A, Zamorano JL, Donal E, Bueno H, Habib G. The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):119-46. doi: 10.1093/ehjci/jeu210. Epub 2014 Nov 6.

    PubMed 25378470

Questions about this trial

What is this clinical trial studying?

An observational study of Dyspnea, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed A Elsayed, MBBCH (01126091101 ext. 02, ahmeda.abdelmoniem@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differentiate between different etiologies of acute dyspnea (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05647655, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in